HEADER CELL ADHESION 04-OCT-08 3ES6 TITLE CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- TITLE 2 GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN TITLE 3 SEMINAL PLASMA CAVEAT 3ES6 NAG D 1 HAS WRONG CHIRALITY AT ATOM C1 MAN D 4 HAS WRONG CAVEAT 2 3ES6 CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ZINC-ALPHA-2-GLYCOPROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ZN-ALPHA-2-GLYCOPROTEIN, ZN-ALPHA-2-GP; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PROLACTIN-INDUCIBLE PROTEIN; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: PROLACTIN-INDUCED PROTEIN, SECRETORY ACTIN-BINDING PROTEIN, COMPND 9 SABP, GROSS CYSTIC DISEASE FLUID PROTEIN 15, GCDFP-15, GP17 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: SEMINAL FLUID; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 OTHER_DETAILS: SEMINAL FLUID KEYWDS MAJOR HISTOCOMPATIBILITY COMPLEX, PROTEIN-PROTEIN COMPLEX, PROLACTIN KEYWDS 2 INDUCIBLE PROTEIN, ZINC 2-GLYCOPROTEIN, ZAG-PIP COMPLEX, KEYWDS 3 GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ACTIN-BINDING, KEYWDS 4 CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR M.I.HASSAN,S.BILGRAMI,V.KUMAR,N.SINGH,S.YADAV,P.KAUR,T.P.SINGH REVDAT 7 01-NOV-23 3ES6 1 HETSYN LINK REVDAT 6 29-JUL-20 3ES6 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 25-DEC-19 3ES6 1 SEQADV SEQRES LINK REVDAT 4 13-JUL-11 3ES6 1 VERSN REVDAT 3 24-FEB-09 3ES6 1 VERSN REVDAT 2 25-NOV-08 3ES6 1 JRNL REVDAT 1 28-OCT-08 3ES6 0 SPRSDE 28-OCT-08 3ES6 2ICN JRNL AUTH M.I.HASSAN,S.BILGRAMI,V.KUMAR,N.SINGH,S.YADAV,P.KAUR, JRNL AUTH 2 T.P.SINGH JRNL TITL CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC JRNL TITL 2 ALPHA2-GLYCOPROTEIN (ZAG) AND PROLACTIN-INDUCIBLE PROTEIN JRNL TITL 3 (PIP) FROM HUMAN SEMINAL PLASMA JRNL REF J.MOL.BIOL. V. 384 663 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18930737 JRNL DOI 10.1016/J.JMB.2008.09.072 REMARK 2 REMARK 2 RESOLUTION. 3.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 10296 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 515 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.23 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 728 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 47 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3217 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 137 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.36000 REMARK 3 B22 (A**2) : 0.36000 REMARK 3 B33 (A**2) : -0.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.467 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.302 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.393 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.911 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.891 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3450 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4698 ; 1.302 ; 1.994 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 393 ; 5.830 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 167 ;40.911 ;24.731 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 554 ;19.027 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;18.434 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 519 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2587 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1317 ; 0.210 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2240 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 83 ; 0.125 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 42 ; 0.269 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.139 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1983 ; 0.431 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3221 ; 0.787 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1467 ; 0.663 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1477 ; 1.200 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3ES6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049700. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10296 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.13900 REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.25 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.52300 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ZAG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM SODIUM ACETATE, 20% PEG4000, REMARK 280 PH6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 66.14900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 66.14900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 66.14900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 66.14900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 66.14900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.14900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 66.14900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.14900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 278 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 231 CZ ARG A 231 NH2 0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 2 O - C - N ANGL. DEV. = -12.9 DEGREES REMARK 500 LEU A 69 CA - CB - CG ANGL. DEV. = 15.5 DEGREES REMARK 500 ILE B 9 N - CA - CB ANGL. DEV. = -15.8 DEGREES REMARK 500 ILE B 9 N - CA - C ANGL. DEV. = 34.5 DEGREES REMARK 500 PHE B 12 CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 GLU B 23 CA - CB - CG ANGL. DEV. = 20.6 DEGREES REMARK 500 LYS B 35 CD - CE - NZ ANGL. DEV. = 14.4 DEGREES REMARK 500 ASP B 73 CA - CB - CG ANGL. DEV. = 24.2 DEGREES REMARK 500 TYR B 75 CA - CB - CG ANGL. DEV. = 12.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 2 -110.52 -130.74 REMARK 500 GLN A 4 -86.26 -72.87 REMARK 500 ASP A 5 110.13 47.55 REMARK 500 ASN A 34 -126.83 55.90 REMARK 500 LYS A 44 -76.72 -70.64 REMARK 500 ASN A 89 -5.05 55.38 REMARK 500 TYR A 124 -62.10 -106.15 REMARK 500 GLU A 164 -52.97 -134.88 REMARK 500 PRO A 212 -175.36 -69.41 REMARK 500 ASP B 2 -69.25 -131.59 REMARK 500 ASN B 3 -65.56 -109.08 REMARK 500 LYS B 6 94.62 57.26 REMARK 500 ILE B 8 -122.97 75.00 REMARK 500 PHE B 12 149.13 -174.94 REMARK 500 ASP B 13 -130.35 -137.23 REMARK 500 PRO B 15 153.52 -42.40 REMARK 500 VAL B 18 -161.30 -127.03 REMARK 500 LYS B 35 -5.54 63.14 REMARK 500 ASP B 97 14.01 58.33 REMARK 500 ALA B 99 54.91 -91.01 REMARK 500 ASN B 107 -11.68 -148.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PCA A 1 GLU A 2 -133.35 REMARK 500 ILE B 8 ILE B 9 140.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ILE B 8 -11.04 REMARK 500 REMARK 500 REMARK: NULL DBREF 3ES6 A 1 278 UNP P25311 ZA2G_HUMAN 18 295 DBREF 3ES6 B 1 118 UNP P12273 PIP_HUMAN 29 146 SEQRES 1 A 278 PCA GLU ASN GLN ASP GLY ARG TYR SER LEU THR TYR ILE SEQRES 2 A 278 TYR THR GLY LEU SER LYS HIS VAL GLU ASP VAL PRO ALA SEQRES 3 A 278 PHE GLN ALA LEU GLY SER LEU ASN ASP LEU GLN PHE PHE SEQRES 4 A 278 ARG TYR ASN SER LYS ASP ARG LYS SER GLN PRO MET GLY SEQRES 5 A 278 LEU TRP ARG GLN VAL GLU GLY MET GLU ASP TRP LYS GLN SEQRES 6 A 278 ASP SER GLN LEU GLN LYS ALA ARG GLU ASP ILE PHE MET SEQRES 7 A 278 GLU THR LEU LYS ASP ILE VAL GLU TYR TYR ASN ASP SER SEQRES 8 A 278 ASN GLY SER HIS VAL LEU GLN GLY ARG PHE GLY CYS GLU SEQRES 9 A 278 ILE GLU ASN ASN ARG SER SER GLY ALA PHE TRP LYS TYR SEQRES 10 A 278 TYR TYR ASP GLY LYS ASP TYR ILE GLU PHE ASN LYS GLU SEQRES 11 A 278 ILE PRO ALA TRP VAL PRO PHE ASP PRO ALA ALA GLN ILE SEQRES 12 A 278 THR LYS GLN LYS TRP GLU ALA GLU PRO VAL TYR VAL GLN SEQRES 13 A 278 ARG ALA LYS ALA TYR LEU GLU GLU GLU CYS PRO ALA THR SEQRES 14 A 278 LEU ARG LYS TYR LEU LYS TYR SER LYS ASN ILE LEU ASP SEQRES 15 A 278 ARG GLN ASP PRO PRO SER VAL VAL VAL THR SER HIS GLN SEQRES 16 A 278 ALA PRO GLY GLU LYS LYS LYS LEU LYS CYS LEU ALA TYR SEQRES 17 A 278 ASP PHE TYR PRO GLY LYS ILE ASP VAL HIS TRP THR ARG SEQRES 18 A 278 ALA GLY GLU VAL GLN GLU PRO GLU LEU ARG GLY ASP VAL SEQRES 19 A 278 LEU HIS ASN GLY ASN GLY THR TYR GLN SER TRP VAL VAL SEQRES 20 A 278 VAL ALA VAL PRO PRO GLN ASP THR ALA PRO TYR SER CYS SEQRES 21 A 278 HIS VAL GLN HIS SER SER LEU ALA GLN PRO LEU VAL VAL SEQRES 22 A 278 PRO TRP GLU ALA SER SEQRES 1 B 118 GLN ASP ASN THR ARG LYS ILE ILE ILE LYS ASN PHE ASP SEQRES 2 B 118 ILE PRO LYS SER VAL ARG PRO ASN ASP GLU VAL THR ALA SEQRES 3 B 118 VAL LEU ALA VAL GLN THR GLU LEU LYS GLU CYS MET VAL SEQRES 4 B 118 VAL LYS THR TYR LEU ILE SER SER ILE PRO LEU GLN GLY SEQRES 5 B 118 ALA PHE ASN TYR LYS TYR THR ALA CYS LEU CYS ASP ASP SEQRES 6 B 118 ASN PRO LYS THR PHE TYR TRP ASP PHE TYR THR ASN ARG SEQRES 7 B 118 THR VAL GLN ILE ALA ALA VAL VAL ASP VAL ILE ARG GLU SEQRES 8 B 118 LEU GLY ILE CYS PRO ASP ASP ALA ALA VAL ILE PRO ILE SEQRES 9 B 118 LYS ASN ASN ARG PHE TYR THR ILE GLU ILE LEU LYS VAL SEQRES 10 B 118 GLU MODRES 3ES6 ASN A 239 ASN GLYCOSYLATION SITE MODRES 3ES6 ASN B 77 ASN GLYCOSYLATION SITE MODRES 3ES6 PCA A 1 GLN PYROGLUTAMIC ACID HET PCA A 1 8 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NDG C 5 14 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET CO3 A 688 4 HET P6G A 701 19 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM CO3 CARBONATE ION HETNAM P6G HEXAETHYLENE GLYCOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 1 PCA C5 H7 N O3 FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 2(C6 H12 O6) FORMUL 3 NDG C8 H15 N O6 FORMUL 5 CO3 C O3 2- FORMUL 6 P6G C12 H26 O7 HELIX 1 1 GLY A 52 GLN A 56 5 5 HELIX 2 2 ASP A 62 TYR A 88 1 27 HELIX 3 3 ALA A 140 GLU A 149 1 10 HELIX 4 4 VAL A 153 GLU A 164 1 12 HELIX 5 5 GLU A 164 ASP A 182 1 19 HELIX 6 6 GLY B 52 TYR B 56 5 5 HELIX 7 7 CYS B 95 ALA B 99 5 5 SHEET 1 A 8 GLN A 49 PRO A 50 0 SHEET 2 A 8 LEU A 36 ASN A 42 -1 N ARG A 40 O GLN A 49 SHEET 3 A 8 PHE A 27 LEU A 33 -1 N LEU A 33 O LEU A 36 SHEET 4 A 8 ARG A 7 LEU A 17 -1 N THR A 15 O GLN A 28 SHEET 5 A 8 VAL A 96 GLU A 106 -1 O GLY A 99 N TYR A 14 SHEET 6 A 8 ARG A 109 TYR A 119 -1 O LYS A 116 N ARG A 100 SHEET 7 A 8 LYS A 122 ASN A 128 -1 O LYS A 122 N TYR A 119 SHEET 8 A 8 ALA A 133 PRO A 136 -1 O ALA A 133 N ASN A 128 SHEET 1 B 9 SER A 188 GLN A 195 0 SHEET 2 B 9 LYS A 201 PHE A 210 -1 O LYS A 204 N THR A 192 SHEET 3 B 9 THR A 241 VAL A 250 -1 O SER A 244 N ALA A 207 SHEET 4 B 9 LEU A 230 HIS A 236 -1 N HIS A 236 O THR A 241 SHEET 5 B 9 LYS B 57 LEU B 62 -1 O THR B 59 N ARG A 231 SHEET 6 B 9 MET B 38 SER B 46 -1 N MET B 38 O LEU B 62 SHEET 7 B 9 VAL B 80 VAL B 88 -1 O ASP B 87 N LYS B 41 SHEET 8 B 9 ARG B 108 VAL B 117 -1 O PHE B 109 N VAL B 86 SHEET 9 B 9 SER B 17 VAL B 18 1 N VAL B 18 O LYS B 116 SHEET 1 C 4 GLU A 224 GLN A 226 0 SHEET 2 C 4 ILE A 215 ARG A 221 -1 N ARG A 221 O GLU A 224 SHEET 3 C 4 TYR A 258 HIS A 264 -1 O HIS A 261 N HIS A 218 SHEET 4 C 4 LEU A 271 PRO A 274 -1 O VAL A 273 N CYS A 260 SHEET 1 D 3 ILE B 9 LYS B 10 0 SHEET 2 D 3 VAL B 24 THR B 32 -1 O GLN B 31 N LYS B 10 SHEET 3 D 3 LYS B 68 PHE B 74 -1 O LYS B 68 N VAL B 30 SSBOND 1 CYS A 103 CYS A 166 1555 1555 2.03 SSBOND 2 CYS A 205 CYS A 260 1555 1555 2.03 SSBOND 3 CYS B 37 CYS B 63 1555 1555 2.02 SSBOND 4 CYS B 61 CYS B 95 1555 1555 2.03 LINK C PCA A 1 N GLU A 2 1555 1555 1.46 LINK ND2 ASN A 239 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 77 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.45 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.44 LINK O2 MAN C 4 C1 NDG C 5 1555 1555 1.50 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.45 LINK O3 BMA D 3 C1 MAN D 4 1555 1555 1.43 CISPEP 1 ILE A 131 PRO A 132 0 -10.26 CISPEP 2 TYR A 211 PRO A 212 0 2.08 CRYST1 132.298 132.298 73.752 90.00 90.00 90.00 P 4 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007559 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007559 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013559 0.00000 HETATM 1 N PCA A 1 112.103 4.107 30.796 1.00 61.98 N HETATM 2 CA PCA A 1 113.469 4.760 30.522 1.00 61.98 C HETATM 3 CB PCA A 1 114.546 4.311 31.642 1.00 61.94 C HETATM 4 CG PCA A 1 113.597 4.162 32.909 1.00 61.97 C HETATM 5 CD PCA A 1 112.207 3.984 32.326 1.00 61.99 C HETATM 6 OE PCA A 1 111.213 3.807 33.161 1.00 61.92 O HETATM 7 C PCA A 1 114.152 4.365 29.147 1.00 62.00 C HETATM 8 O PCA A 1 114.007 3.040 28.764 1.00 62.02 O